Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors

for
Neoplasms, Chronic Disease
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT05391217

Recruiting

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

for
Ovarian Cancer, Pancreas Cancer, Urothelial Carcinoma,
Location: New York NY, Rochester NY, Atlanta GA, Denver CO,
Sponsor: Nammi Therapeutics Inc

Sex: All

Age: 18+

Code: NCT06582017

Phase 1, Recruiting

STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)

for
Metastatic Breast Cancer
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: Female

Age: 18+

Code: NCT05716516

Phase 2, Recruiting

5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

for
Neoplasms, Solid Tumors
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT03366116

Phase 1, Recruiting

Breast 3DUS ABUS System Comparison

for
Breast Diseases
Location: London
Sponsor: Western University, Canada

Sex: All

Age: 18+

Code: NCT06118996

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Radiotherapy Patient Education With Virtual Reality

for
Anxiety, Cancer
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06506435

Recruiting

Personalized Models for Cancer Research

for
Solid Tumor, Adult
Location: New York NY
Sponsor: New York Stem Cell Foundation Research Institute

Sex: All

Age: 18+

Code: NCT06350539

Recruiting

IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

for
Cancer
Location: Philadelphia PA
Sponsor: State University of New York at Buffalo

Sex: All

Age: 18+

Code: NCT06206941

Recruiting

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06040541

Phase 1, Recruiting

Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Huntersville NC
Sponsor: Nanjing Zenshine Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05118841

Phase 1, Recruiting

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

for
Diabetes Mellitus, Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03415139

Recruiting

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation

for
Advanced Solid Tumors
Location: Orange City FL, Lake City FL, Houston TX
Sponsor: Abion Inc

Sex: All

Age: 18+

Code: NCT05541822

Phase 2, Recruiting

Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.

for
Breast Neoplasms
Location: Vancouver
Sponsor: University of British Columbia

Sex: Female

Age: 19 - 70+

Code: NCT04824339

Recruiting

Prospective Breast Cancer Biospecimen Collection

for
Breast Cancer, Invasive Breast Cancer,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT04074720

Recruiting

Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

for
Symptoms and Signs, Cancer, Childhood Cancer
Location: Richmond VA, Kansas City MO, Salt Lake City UT
Sponsor: Virginia Commonwealth University

Sex: All

Age: 15 - 29

Code: NCT05958316

Recruiting

Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer

for
ER-Positive Breast Cancer, HER2-negative Breast Cancer
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT05305924

Phase 2, Recruiting

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

for
Cancer, Thoracic Cancer, Gynecologic Cancer,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06633224

Recruiting

AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

for
Breast Cancer Invasive, Prostate Cancer
Location: New York NY, Miami Beach FL
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT05351424

Recruiting

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

for
Pancreatic Cancer, Renal Cell Cancer, Breast Cancer, Melanoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT02830724

Phase 1, Phase 2, Recruiting

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, Fairfax VA, Plantation FL, Tamarac FL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05785741

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial